Abstract
It is a tough climate in which to be raising early stage investment but there is funding available for the very best of British biotechnology. This report outlines several sources of funding that the author has found most relevant to early stage biotechnology companies. The competition for the limited funds is harsh so it is vital that biotechnology entrepreneurs choose the right sources of funding and approach them in the right way. The final section briefly outlines how companies can 'tilt the balance' in their favour and learn to move from just being scientifically convincing to becoming a commercially convincing investment opportunity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
